Gossamer Bio, Inc. (GOSS)
11.00
+0.62
(+5.97%)
USD |
NASDAQ |
Sep 16, 16:00
11.00
0.00 (0.00%)
After-Hours: 20:00
Gossamer Bio Market Cap : 67.22M for Sept. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 15, 2026 | 63.43M |
| September 14, 2026 | 65.38M |
| September 11, 2026 | 65.57M |
| September 10, 2026 | 69.61M |
| September 09, 2026 | 78.07M |
| September 08, 2026 | 87.94M |
| September 04, 2026 | 6.856B |
| September 03, 2026 | 6.867B |
| September 02, 2026 | 6.754B |
| September 01, 2026 | 6.547B |
| August 31, 2026 | 6.648B |
| August 28, 2026 | 6.652B |
| August 27, 2026 | 6.652B |
| August 26, 2026 | 6.801B |
| August 25, 2026 | 7.998B |
| August 24, 2026 | 6.844B |
| August 21, 2026 | 6.050B |
| August 20, 2026 | 6.159B |
| August 19, 2026 | 6.124B |
| August 18, 2026 | 5.596B |
| August 17, 2026 | 5.475B |
| August 14, 2026 | 6.030B |
| August 13, 2026 | 6.660B |
| August 12, 2026 | 6.946B |
| August 11, 2026 | 7.110B |
| Date | Value |
|---|---|
| August 10, 2026 | 6.887B |
| August 07, 2026 | 6.961B |
| August 06, 2026 | 6.977B |
| August 05, 2026 | 6.949B |
| August 04, 2026 | 7.098B |
| August 03, 2026 | 6.789B |
| July 31, 2026 | 6.629B |
| July 30, 2026 | 6.973B |
| July 29, 2026 | 8.084B |
| July 28, 2026 | 8.021B |
| July 27, 2026 | 7.798B |
| July 24, 2026 | 5.319B |
| July 23, 2026 | 5.573B |
| July 22, 2026 | 5.655B |
| July 21, 2026 | 6.054B |
| July 20, 2026 | 5.514B |
| July 17, 2026 | 6.652B |
| July 16, 2026 | 6.668B |
| July 15, 2026 | 6.324B |
| July 14, 2026 | 5.479B |
| July 13, 2026 | 5.635B |
| July 10, 2026 | 6.637B |
| July 09, 2026 | 6.844B |
| July 08, 2026 | 6.609B |
| July 07, 2026 | 6.942B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| United Therapeutics Corp. | 21.27B |
| Arbutus Biopharma Corp. | 997.06M |
| Kura Oncology, Inc. | 993.62M |
| ACADIA Pharmaceuticals, Inc. | 4.737B |
| Alnylam Pharmaceuticals, Inc. | 32.03B |
Market Cap Related Metrics
| PS Ratio | 0.6564 |
| PEG Ratio | -0.0144 |
| Price | 11.00 |
| Earnings Yield | -506.1% |
| PEGY Ratio | -0.0144 |